| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $19.89 ▲ +1.41% | Yesterday | $19.49 ▼ -0.59% | Tomorrow's BioAge Labs Inc. Common Stock (BIOA) setup is anchored to $19.61 and targets $19.89 (+1.41%). The near-term read is upside; watch $20.20 / $19.02 because daily realized volatility is about 7.29%. |
Tomorrow's BioAge Labs Inc. Common Stock (BIOA) setup is anchored to $19.61 and targets $19.89 (+1.41%). The near-term read is upside; watch $20.20 / $19.02 because daily realized volatility is about 7.29%. | ||||
| Week | $20.47 ▲ +4.40% | Last Week | $19.25 ▼ -1.85% | The 7-day BioAge Labs Inc. Common Stock model moves from $19.25 to $20.47 (+4.40%). It gives upside momentum context for this stock, so breaks around $20.20 / $19.02 matter more than a single tick. |
The 7-day BioAge Labs Inc. Common Stock model moves from $19.25 to $20.47 (+4.40%). It gives upside momentum context for this stock, so breaks around $20.20 / $19.02 matter more than a single tick. | ||||
| Month | $21.45 ▲ +9.37% | Last Month | $18.84 ▼ -3.94% | The 1-month BioAge Labs Inc. Common Stock target is $21.45 (+9.37%), compared with the live reference near $19.61. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month BioAge Labs Inc. Common Stock target is $21.45 (+9.37%), compared with the live reference near $19.61. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $22.91 ▲ +16.82% | Last Year | $18.22 ▼ -7.07% | The 1-year BioAge Labs Inc. Common Stock scenario points to $22.91 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year BioAge Labs Inc. Common Stock scenario points to $22.91 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $26.33 ▲ +34.29% | 5 Years Ago | $16.79 ▼ -14.40% | The 5-year BioAge Labs Inc. Common Stock view is $26.33 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year BioAge Labs Inc. Common Stock view is $26.33 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $19.61 | Mid |
| Daily Change | +4.31% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 66% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $19.61 | Daily Change | +4.31% |
| Market Cap | $870.29M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.